Search Results 211-220 of 1021 for ���������������������������������������������:PC90���

  1. Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors - Mayo Clinic

    The purpose of part one of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and safety profile of Q901 monotherapy ...

  2. Publications - Erik J. Tryggestad, Ph.D. - Mayo Clinic

    Hallemeier CL, Merrell KW, Neben-Wittich MA, Jethwa KR, Yoon HH, Pitot HC, Blackmon S, Shen KR, Tryggestad EJ, Giffey B, Kazemba BD, Viehman JK, Harmsen WS, ...

  3. Publications

    Publications. Pulukuri SV, Fagle TR, Trujillo-Rodriguez D, van Amerongen S, Bernick C, Geda YE, Wethe JV, Peskind ER, Katz DI, Alosco ML, Palmisano JN, ...

  4. A Study to Evaluate Food on Gastrointestinal Toxicity and The Effect of Selumetinib in Adolescents with Neurofibromatosis Type 1 - Mayo Clinic

    About this study. The purpose of this study in adolescent participants is to evaluate the effect of a low fat meal on steady state selumetinib exposure; ...

  5. The PCI Choice Trial: a Pilot Randomized Trial of a Decision Aid for Patients With Stable Coronary Artery Disease - Mayo Clinic

    About this study. Despite several large clinical trials clearly establishing that coronary revascularization (i.e. percutaneous coronary intervention - PCI) ...

  6. Health Topics - Mayo Clinic News Network

    ROCHESTER, Minn. — An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in Oxford, ...

  7. Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung - Mayo Clinic

    About this study. The purpose of this study is to compare the effect of immunotherapy with atezolizumab in combination with standard chemotherapy with a ...

  8. Patient Stories - Philippe R. Bauer, M.D., Ph.D. - Mayo Clinic

    Philippe R. Bauer, M.D., Ph.D. Critical Care Specialist; Internist; Pulmonologist. Request an Appointment.

  9. Medical Research & Education - Mayo Clinic News Network

    JACKSONVILLE, Fla. — Mayo Clinic's pioneering exploration of stem cell-based therapies for bone loss is headed to space. Abba Zubair, M.D., Ph.D., ...

  10. Gastrointestinal Stromal Tumor Clinical Trials - Mayo Clinic Research

    The purpose of this study is to investigate the effect of Avapritinib on the pharmacokinetics of Midazolam in patients with unresectable or metastatic ...